Vascularized Ventricular Cardiac Organoid

  • Vascularized Ventricular Cardiac Organoid

Human iPSC-derived Vascularized Ventricular Cardiac Organoid

These advanced organoids incorporate both ventricular cardiomyocytes and vascular endothelial networks, providing a more physiologically relevant 3D cardiac tissue model. They exhibit improved nutrient diffusion, chamber-specific electrophysiology, and long-term functionality.

Benefits

  • Combines ventricular cardiac and vascular endothelial compartments
  • Enhanced longevity and maturation in culture
  • Ideal for drug safety testing, regenerative medicine, and disease modeling

Product Specifications

Feature

Detail

Identity Markers

Ventricular markers (MLC2v, TNNT2) + endothelial markers (CD31, VE-Cadherin)

Quantities

≥ 1 × 10⁶ cells per vascularized organoid

Quality Control

Electrophysiology, contractility, vascular perfusion assays, mycoplasma testing

Format

Cryopreserved vascularized 3D organoids

Donor & Reprogramming

Healthy donor; Sendai virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C

Supplied with

Specialized culture medium and user instructions

Explore Vascularized Ventricular Cardiac Organoid

Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.

Our Products